Telangana DCA Seizes Overpriced ‘ICONE-200’ At Pharmacy In Quthbullapur

Hyderabad: The Drugs Control Administration, Telangana seized antifungal medicine ‘ICONE-200 Capsules’ (Itraconazole Capsules 200 mg) at Quthbullapur Village, Medchal-Malkajgiri district for over-pricing.

According to the DCA officials, the MRP indicated is very high compared to the ceiling price fixed for the product by the central government.

Upon information, the DCA raided a medical shop located in Quthbullapur Village, Medchal-Malkajgiri district on Monday, July 22.

The product Itraconazole Capsules 200 mg sold under the brand name ‘ICONE-200 Capsules’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of the product shall be as per the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), government of India.

The Central government has set the ceiling price for Itraconazole Capsules 200 mg at Rs 22.12 per capsule, based on the Wholesale Price Index (WPI). However, Mascot Health Series Private Limited is selling the product for Rs 441.24 for a pack of 10 capsules, which amounts to Rs 44.12 per capsule. This pricing violates the Drugs (Prices Control) Order, 2013.

Mascot Health Series Private Limited which is marketing the product selling for Rs 441.24 for 10 capsules i.e. Rs. 44.12 per one capsule, on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

“The firm overpriced the product. The firm charged an excess of Rs 193.5 for 10 capsules,” said DCA officials.

Further investigation will be carried out and action shall be taken as per the law against all the offenders.

Related Posts

KGMU prof suspended for forcing patients to buy meds from pvt store

Lucknow: Faculty member in the ophthalmology department of KGMU, Prof Sanjiv Gupta, was suspended on charges of prescribing medicines and lenses for cataract surgery that were available at a private…

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

New Delhi: The pharmacovigilance division of the Central drug regulator has received a total of 1,387 adverse reports, with the highest regarding fixed dose combinations (FDCs), and a total of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

KGMU prof suspended for forcing patients to buy meds from pvt store

KGMU prof suspended for forcing patients to buy meds from pvt store

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports